Stem Inc (STEM)

[BananaApes]

For anyone interested in Stem Cell...some DD included. GL


U.S. Stem Cell, Inc.
Regenerative Stem Cell Medicine

Ticker: USRM
Current Stock Price: 0.028 cents
Shares Outstanding 5 5.04M
Float 3.81M

Kristin Comella, Chief Science Officer

U.S. Stem Cell: http://us-stemcell.com/en/home-2/

U.S. Stem Cell Clinic: http://usstemcellclinic.com/

U.S. Stem Cell Vetbiologics: http://www.vetbiologics.com/

U.S. Stem Cell Training: https://www.usstemcelltraining.com/

U.S. Stem Cell FDA Clinical Trials: http://us-stemcell.com/en/clinical-trials/
__________________________________________________________

Bloomberg Article - Regenerative medicine could be a $120 billion industry by 2030

Stem Cell Crusader Sparks New Hope for Fighting Diabetes, Heart Disease
Regenerative medicine could be a $120 billion industry by 2030.
Published: June 27, 2016

http://www.bloomberg.com/news/features/2016-06-27/stem-cell-crusader-sparks-new-hope-for-fighting-diabetes-heart-disease
__________________________________________________________

Nobel Prize Winner

TOP 50 most influential people on Stem Cells today
http://www.cirm.ca.gov/sites/default/files/files/press_release/Top_50_Global_Stem_Cell_Influencers.pdf

Rank #1 Dr Shinya Yamanaka - Nobel Prize Winner

Nobel Prizes and Laureates
https://www.nobelprize.org/nobel_prizes/medicine/laureates/2012/yamanaka-facts.html

Rank #24 Kristin Comella - USRM Chief Science Officer

"She was named number 24 on Terrapin’s list of the Top 50 Global Stem Cell Influencers and number 1 on the Academy of
Regenerative Practices list of Top 10 Stem Cell Innovators."

"Ms. Comella has pioneered stem cell therapies from various sources including cord blood, bone marrow, muscle, and adipose.
She led the team that gained the first ever FDA approval for a clinical trial using a combined cell and gene therapy product in the heart."

Academy of Regenerative Practices
https://regenerativeacademy.com/

Academy of Regenerative Practices list of Top 10 Stem Cell Innovators
https://regenerativeacademy.com/top-ten-stem-cell-innovators/

Rank #1 Kristin Comella - USRM Chief Science Officer
__________________________________________________________

Published By Kristin Comella, USRM Chief Science Officer

Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy
CSO Kristin Comella Publishes Paper on the Implantation of Stromal Vascular Fraction in Patients with Cardiomyopathy

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890248/pdf/12967_2016_Article_918.pdf
https://finance.yahoo.com/news/cso-kristin-comella-publishes-paper-130000318.html

CSO Kristin Comella Publishes Paper on the Integration of Stem Cells to Chondrocyte Derived Cartilage
http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0149121#sec030
__________________________________________________________

U.S. Stem Cell Announces Positive Results for Traumatic Brain Injury (TBI) Patients
https://finance.yahoo.com/news/u-stem-cell-announces-positive-140000816.html

CSO Kristin Comella Publishes Paper on the Integration of Stem Cells to Chondrocyte Derived Cartilage
http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0149121#sec030

Testimonials
http://usstemcellclinic.com/testimonials/
__________________________________________________________

VIDEOS:

USRM has FDA approved trials for a $1 billion market opportunity...
http://ih.advfn.com/videos/stock-research/bhrt-ceo-s-powerful-clip-from-american-investor-documentary_taK_CLj3KyU

USRM has FDA authorization for Phase I, II, & III
http://ih.advfn.com/videos/educational/bioheart-bhrt_qZUSwJTh-SQ

USRM - SmallCap Voice Interview...FDA approval studies and clinical trials
http://ih.advfn.com/videos/stock-research/5-28-14-smallcapvoice-interview-with-bioheart-inc-bhrt_T9UkUxA2wWo